Head of Pulmonary Center of KSFH, CEO of AIR Plus Clinic, BoD of Cambodian Pulmonary Association
Chronic Obstructive Pulmonary Disease (COPD) management has evolved significantly with newer evidence-based updates focusing on early diagnosis, personalized therapy, and prevention of disease progression. Recent guidelines emphasize optimized use of long-acting bronchodilators, dual and triple inhaler therapies, and a more selective role of inhaled corticosteroids based on exacerbation risk and eosinophil counts. Non-pharmacological strategies such as pulmonary rehabilitation, smoking cessation, and vaccination remain central to improving outcomes. Advances in inhaler technology, digital monitoring, and tele-pulmonology are also transforming long-term disease management. These updates aim to reduce exacerbations, improve quality of life, and support clinicians in delivering more precise, patient-centered COPD care.
Head of Pulmonary Center of KSFH, CEO of AIR Plus Clinic, BoD of Cambodian Pulmonary Association
Dr. Meng Va is a leading pulmonologist from Phnom Penh, Cambodia, with over nine years of clinical and leadership experience in respiratory and sleep medicine. He is the Founder and CEO of AIR Plus Clinic, where he has been spearheading patient-centered pulmonary care since 2017, and later expanded his vision by establishing the clinic as an independent practice in 2022. In parallel, he serves at Khmer–Soviet Friendship Hospital (KSFH) as the Head of the Pulmonary Center and has played a pivotal role as Deputy of COVID-19 management, contributing significantly to national pandemic response efforts. Academically, he holds a Master’s degree in Pulmonology from Université de Rouen, France, and further advanced training in Pulmonology from the University of Health and Science, underscoring his strong foundation in evidence-based respiratory care and clinical leadership.
Copy Link